Ovid Therapeutics (OVID) Prepaid Assets (2016 - 2026)

Ovid Therapeutics has reported Prepaid Assets for 11 years, with the latest figure at $4.6 million in Q1 2026.

• For the quarter ending Q1 2026, Prepaid Assets rose 58.05% year-over-year to $4.6 million; the trailing twelve-month figure through Mar 2026 stood at $4.6 million (up 58.05% YoY), and the FY2025 full-year result was $4.7 million, up 65.2% from the prior year.
• Prepaid Assets for Q1 2026 stood at $4.6 million, down from $4.7 million in the prior quarter.
• The five-year high for Prepaid Assets was $5.7 million in Q2 2023, with the low at $1.8 million in Q1 2023.
• Historically, Prepaid Assets has averaged $3.4 million across 5 years, with a median of $3.1 million in 2024.
• Annual changes were most pronounced in 2023 — Prepaid Assets jumped 108.22% — and 2024, when it plunged 32.89%.
• Ovid Therapeutics' Prepaid Assets stood at $2.4 million in 2022, then jumped by 58.16% to $3.8 million in 2023, then declined by 23.86% to $2.9 million in 2024, then jumped by 65.2% to $4.7 million in 2025, then fell by 2.32% to $4.6 million in 2026.
• The last three Prepaid Assets figures came in at $4.6 million (Q1 2026), $4.7 million (Q4 2025), and $3.2 million (Q3 2025), per Business Quant data.